Table 1.
Clinical characteristics of all included patients.
| MND | Disease Controls | Healthy Controls | p Value | ||
|---|---|---|---|---|---|
| Number of patients | 47 | 34 | 33 | ||
| Gender | Male (%) | 28 (59.6) | 22 (64.7) | 13 (39.4) | 0.085 |
| Female (%) | 19 (40.4) | 12 (35.3) | 20 (60.6) | ||
| Median age at sampling years (IQR) | 65 (58, 75) | 56 (40.8, 66.3) | 59 (51, 68.5) | <0.001 | |
| Disease subcategories | 34 ALS | 8 Myopathies | |||
| 8 PMA | 7 SMA | ||||
| 5 PLS | 6 Neuropathies | ||||
| 6 PD | |||||
| 5 SBMA | |||||
| 2 MG | |||||
ALS—amyotrophic lateral sclerosis, PMA—progressive muscular atrophy, PLS—primary lateral sclerosis, SMA—spinal muscular atrophy, SBMA—spinal bulbar muscular atrophy, PD—Parkinson’s disease, MG—myasthenia gravis.